These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 10421643

  • 1. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, Wang J, Wu Y, Liu G, Wu Y, Zhu Y.
    Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
    [Abstract] [Full Text] [Related]

  • 2. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 3. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD.
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [Abstract] [Full Text] [Related]

  • 4. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
    Yu MW, Hsieh HH, Pan WH, Yang CS, CHen CJ.
    Cancer Res; 1995 Mar 15; 55(6):1301-5. PubMed ID: 7882326
    [Abstract] [Full Text] [Related]

  • 5. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, Sun Z.
    Hepatology; 2002 Nov 15; 36(5):1214-20. PubMed ID: 12395332
    [Abstract] [Full Text] [Related]

  • 6. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    Gastroenterology; 2012 May 15; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [Abstract] [Full Text] [Related]

  • 7. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ.
    Hepatology; 1999 Mar 15; 29(3):697-702. PubMed ID: 10051470
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ.
    J Natl Cancer Inst; 2005 Feb 16; 97(4):265-72. PubMed ID: 15713961
    [Abstract] [Full Text] [Related]

  • 9. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul 16; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 10. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC, Yuan JM, Ross RK, Govindarajan S.
    Hepatology; 1997 Jan 16; 25(1):226-8. PubMed ID: 8985295
    [Abstract] [Full Text] [Related]

  • 11. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 16; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 12. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA.
    Mutat Res; 2008 Nov 16; 659(1-2):176-84. PubMed ID: 18346933
    [Abstract] [Full Text] [Related]

  • 13. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep 16; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 14. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K, Chen JG, Cui Y, Gong YY, Turner PC, Villar S, Wild CP, Parkin DM, Hainaut P.
    Cancer Epidemiol Biomarkers Prev; 2009 May 16; 18(5):1638-43. PubMed ID: 19366907
    [Abstract] [Full Text] [Related]

  • 15. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, Wu MC, Gao B, Hou LF, Zhu GS.
    Cancer Lett; 2005 Nov 08; 229(1):77-83. PubMed ID: 15979781
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L.
    Rev Esp Enferm Dig; 2000 Jul 15; 92(7):458-69. PubMed ID: 11026763
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.
    J Natl Cancer Inst; 2009 Jul 15; 101(14):1019-27. PubMed ID: 19535774
    [Abstract] [Full Text] [Related]

  • 19. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB, Richardson PA, Everhart JE.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2462-7. PubMed ID: 11513191
    [Abstract] [Full Text] [Related]

  • 20. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 15; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.